Skip to content
stoqly
en

Languages

Figures come from SEC filings, which are in English. Company and industry names stay as filed.

$ USD

Popular

All currencies

Data is in US dollars, converted at the ECB reference rate of Oct 23, 2026.

DuPont

DD NYSE Industrial Conglomerates Financials FY2016–FY2025

DuPont makes engineered materials and parts for other businesses. Its products include medical packaging and components for medical devices and drug makers, water filters and membranes that clean water for industry and cities, building materials such as TYVEK house wrap, STYROFOAM insulation and CORIAN countertops, and industrial parts, adhesives, lubricants and printing plates for aircraft, car and packaging makers. It has subsidiaries in about 50 countries and factories in about 20.

Download report 3-page PDF: the company, its results and charts with peers.

Last close Β· Oct 23, 2026

$136.55

1.1%
Value it Compare

What DuPont does

DD Β· Industrial Conglomerates

From its latest annual report

DuPont makes engineered materials and parts for other businesses. Its products include medical packaging and components for medical devices and drug makers, water filters and membranes that clean water for industry and cities, building materials such as TYVEK house wrap, STYROFOAM insulation and CORIAN countertops, and industrial parts, adhesives, lubricants and printing plates for aircraft, car and packaging makers. It has subsidiaries in about 50 countries and factories in about 20.

It reports two segments. Healthcare & Water Technologies had net sales of $3,233 million in 2025, and Diversified Industrials, which covers the building and industrial products, had $3,616 million. Sales outside the US, including exports, made up about 53 percent of the total. DuPont says it competes with large multinational companies and established regional ones, on technology, price and service.

The company has been shrinking to this core. On November 1, 2025 it spun off its electronics business as a separate public company, Qnity Electronics, and it has agreed to sell its Aramids business to Arclin, a deal it said it expected to close around the end of the first quarter of 2026. At the end of 2025 DuPont employed about 15,000 people, about 1,700 of them in the Aramids business, and half of its workforce was in the US and Canada.

Filing details

Legal name
DUPONT DE NEMOURS, INC.
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 17, 2026
Accession Β· CIK
0001666700-26-000013 Β· 0001666700
Biggest risks, in its own words

KIRA’s summary AI analyst

Hi! I read DuPont’s latest annual report (fiscal 2025). Here is what stands out:

2 strengths 2 to watch

1.Sales and profit

See section β†’
  • DuPont had $6.8B of revenue in fiscal 2025, up 1.9% on the year before. Over five years, revenue changed βˆ’19.6% a year on average.
  • DuPont lost $779M in fiscal 2025.

2.Cash and shareholders

See section β†’
  • Free cash flow was $227M in fiscal 2025, 3.3% of revenue.
  • DuPont returned $597M to shareholders in fiscal 2025, 263% of free cash flow. The diluted share count rose 0.0%.
  • In the last 12 months, insiders sold $0.6M of shares on the open market and bought none.

3.Financial health

See section β†’
  • DuPont owes $2.5B more than it holds in cash, about 2.1 years of operating profit.
  • Its return on capital was 1.1%: every 100 invested in the business earned about 1 in a year.
  • DuPont passes 6 of 9 financial health tests (Piotroski F-score).

Biggest risks, in its own words

  • Large tax bills if past spin-offs and sales, including the Qnity spin-off, fail to qualify for their intended tax treatment.
  • Lawsuits and cleanup costs tied to PFAS chemicals, shared with Corteva and Chemours under a cost-sharing agreement.
  • The planned sale of the Aramids business may be delayed or may not happen as planned.
  • Its reliance on energy, raw materials and outside suppliers spread across many countries, which can be disrupted.
  • Trade disputes and tariffs that could raise its costs or make its products less competitive abroad.

DuPont in 30 seconds

Good So-so Weak

So-so

Are sales growing?

+1.9%

Only a little. Sales grew 1.9% last year.

Weak

Does it make a profit?

βˆ’11.4%

No. It lost money last year.

So-so

Does profit turn into cash?

3.3%

Partly. 3.3% of sales ends up as free cash.

So-so

Is debt under control?

2.1x

Keep an eye on it. Repaying its debt would take 2.1 years of operating profit.

So-so

How healthy are the accounts?

6 / 9

Mixed. It passes 6 of 9 health tests.

Rules of thumb on reported numbers. A starting point, not a recommendation.

Key numbers, fiscal 2025

Market cap Last close times the latest diluted share count, so it is approximate.
$18.7B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”

Revenue

Total sales reported in the income statement.

KIRA Β· DuPont had $6.8B of revenue in fiscal 2025, up 1.9% on the year before. Over five years, revenue changed βˆ’19.6% a year on average.

See the full section β†’

Operating margin

Operating income as a share of revenue.

See the full section β†’

Net income

Profit after all expenses, interest and tax.

KIRA Β· DuPont lost $779M in fiscal 2025.

See the full section β†’

Free cash flow

Cash from operations minus capital spending.

KIRA Β· Free cash flow was $227M in fiscal 2025, 3.3% of revenue.

See the full section β†’

Return on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

KIRA Β· Its return on capital was 1.1%: every 100 invested in the business earned about 1 in a year.

See the full section β†’

About these figures. Share counts and per-share figures for earlier years are restated for a stock split (1-for-3.003), so every year is on today's share basis.

Charts by

Sales and profit

Is it selling more, and how much does it keep?

Results dates

In plain words: Every quarter, companies publish how much they sold and earned. These are the days DuPont did it, and the next one. Share prices often move a lot on those days.

Next results

November 3, 2026

Tuesday Β· in 8 days

Time
Before the market opens
Covers
Period ended Sep 30, 2026
Expected EPS
$1.86
Source
Earnings calendar
See who else reports that week β†’
Date Results for Time Source
Aug 4, 2026 Q2 '26 Before the market opens 8-K β†—
May 5, 2026 Q1 '26 Before the market opens 8-K β†—
Feb 10, 2026 Q4 '25 Before the market opens 8-K β†—
Nov 6, 2025 Q3 '25 Before the market opens 8-K β†—
Aug 5, 2025 Q2 '25 Before the market opens 8-K β†—
May 2, 2025 Q1 '25 Before the market opens 8-K β†—
Feb 11, 2025 Q4 '24 Before the market opens 8-K β†—
Nov 5, 2024 Q3 '24 Before the market opens 8-K β†—

From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.

Revenue and margins

KIRA Β· DuPont had $6.8B of revenue in fiscal 2025, up 1.9% on the year before. Over five years, revenue changed βˆ’19.6% a year on average.

In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).

Revenue

Revenue

Margins, % of revenue

Gross Operating Net FCF

Margins, % of revenue

Gross Operating Net FCF

Net income and earnings per share

KIRA Β· DuPont lost $779M in fiscal 2025.

Loss periods are shown in red.

In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.

Net income

Net income

Diluted EPS

Diluted EPS

Cash and shareholders

How much cash comes in, and where does it go?

Cash flow

KIRA Β· Free cash flow was $227M in fiscal 2025, 3.3% of revenue.

Cash from operations minus capital spending.

In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.

Free cash flow

Free cash flow

Cash from operations vs capital spending

Cash from operations Capital spending

Cash from operations vs capital spending

Cash from operations Capital spending

Dividends, buybacks and share count

KIRA Β· DuPont returned $597M to shareholders in fiscal 2025, 263% of free cash flow. The diluted share count rose 0.0%.

In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).

Dividends and buybacks

Dividends Buybacks

Dividends and buybacks

Dividends Buybacks

Diluted shares outstanding (annual)

Insider trades

KIRA Β· In the last 12 months, insiders sold $0.6M of shares on the open market and bought none.

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. β€œPlan” marks trades under a pre-arranged Rule 10b5-1 plan.

In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.6M

2 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Jun 2, 2026 Lori KochCEO, Director Sold 261 $48.82 $0.0M Form 4
Nov 28, 2025 Erik T. HooverSVP & General Counsel Sold 6,005 $39.79 $0.2M Form 4
Nov 28, 2025 Lori KochCEO, Director Sold 9,011 $39.46 $0.4M Form 4

Financial health

Can it carry its debts, and how well does it use its money?

Balance sheet

KIRA Β· DuPont owes $2.5B more than it holds in cash, about 2.1 years of operating profit.

Cash, debt and the ratios that show how comfortably DuPont can carry it.

In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.

Cash vs debt (incl. leases)

Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $2.0B$5.0B$2.4B$1.8B$715M
Debt incl. finance leases $10.8B$8.1B$7.9B$7.2B$3.2B
Net debt / EBITDA 2.9x1.0x7.8x4.8x2.1x
Debt / equity 0.4x0.3x0.3x0.3x0.2x
Interest coverage 3.8x3.9x0.3x1.3x1.6x
Current ratio 2.9x3.0x2.4x3.8x2.4x
Quick ratio 2.5x2.4x1.7x3.6x1.9x
Total assets $45.7B$41.4B$38.6B$36.6B$21.6B
Total liabilities $18.7B$14.3B$13.8B$12.8B$7.5B
Shareholders' equity $26.4B$26.6B$24.3B$23.4B$13.9B
Net debt (βˆ’ = net cash) $8.8B$3.2B$5.5B$5.4B$2.5B

Returns on capital

KIRA Β· Its return on capital was 1.1%: every 100 invested in the business earned about 1 in a year.

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.

Return on capital, equity and assets (annual)

Return on capital Return on equity Return on assets

Piotroski F-score

KIRA Β· DuPont passes 6 of 9 financial health tests (Piotroski F-score).

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.

TestFY23FY24FY25
Net income is positive βœ“ βœ“ βœ•
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ• βœ“ βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“
Debt fell relative to assets βœ• βœ“ βœ“
Current ratio rose βœ• βœ“ βœ•
Share count didn't rise βœ“ βœ“ βœ“
Gross margin rose βœ• βœ“ βœ“
Revenue rose relative to assets βœ• βœ“ βœ“
F-score 4 / 99 / 96 / 9
Accruals ratio βˆ’1.1%βˆ’0.2%βˆ’4.6%
Altman Z'' 0.722.72βˆ’0.53

Price and value

What does the share cost, and how does it compare?

Value DuPont yourself

KIRA Β· At $136.55 a share, the company is worth $18.7B.

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

In plain words: Move the sliders to try your own guesses about growth. The result is what one share would be worth if those guesses came true. Different guesses give very different answers.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$2.5B and divides by 419.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Similar companies

KIRA Β· DuPont grew sales faster than 3 of its 4 similar companies.

Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.

In plain words: The same numbers for similar companies, so you can tell whether a figure is high or low for this kind of business.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
DuPont DD $18.7B 1.9% β€” 3.3% 1.1% β€” 6
Carlisle Companies CSL $14.0B 0.3% 20.0% 19.3% 21.9% 19.8x 6 Compare β†’
3M MMM $90.7B 1.5% 18.6% 5.6% 34.2% 25.9x 5 Compare β†’
Honeywell Technologies HON $70.6B 7.9% 21.7% 14.5% 17.1% β€” 4 Compare β†’
ZIM Integrated Shipping ZIM $3.5B βˆ’18.1% 14.7% 30.2% 24.9% β€” 4 Compare β†’

All figures

Every number, year by year.

10 years of figures

Amounts in USD. Hover a ratio’s name for its definition.

In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $48.2B $11.7B $22.6B $21.5B $20.4B $12.6B $13.0B $6.6B $6.7B $6.8B
Gross profit $10.5B $12.7B $20.6B $11.5B $13.3B $4.6B $4.6B $2.2B $2.2B $2.4B
Research and development $1.6B $657M $1.1B $689M $565M $557M $536M $192M $203M $193M
Interest expense $858M $0.0M $55.0M $667M $672M $525M $492M $396M $366M $313M
Pretax income $4.4B βˆ’$1.5B $600M βˆ’$126M βˆ’$1.3B $1.4B $1.4B βˆ’$279M $117M $200M
Income tax $9.0M βˆ’$1.8B $195M βˆ’$2.0M $90.0M $237M $387M βˆ’$217M $213M $102M
Net income $4.3B $1.2B $3.8B $498M βˆ’$3.0B $6.5B $5.9B $423M $703M βˆ’$779M
Diluted EPS $10.56 $2.15 $4.96 $0.67 βˆ’$4.01 $11.89 $11.75 $0.94 $1.68 βˆ’$1.86
Diluted shares 0.37B 0.53B 0.77B 0.75B 0.74B 0.54B 0.50B 0.45B 0.42B 0.42B
Cash flow
Cash from operations βˆ’$3.0B βˆ’$765M $4.7B $1.4B $4.1B $2.3B $588M $845M $765M $560M
Capital expenditure $3.8B $551M $1.2B $2.5B $1.2B $788M $662M $302M $285M $333M
Free cash flow βˆ’$6.8B βˆ’$1.3B $3.5B βˆ’$1.1B $2.9B $1.5B βˆ’$74.0M $543M $480M $227M
Depreciation and amortization $2.9B $1.1B $2.2B $3.2B $3.1B $1.1B $1.1B $580M $635M $647M
Stock-based compensation $261M $19.0M $92.0M $87.0M $93.0M $67.0M $75.0M $57.0M $56.0M $38.0M
Acquisitions $187M $50.0M $20.0M $180M $70.0M $2.3B $5.0M $1.8B $313M $55.0M
Share buybacks $916M $1.0B $4.4B $2.3B $232M $2.1B $0.0M $0.0M $0.0M $0.0M
Dividends paid $2.5B $3.4B $3.5B $1.6B $882M $630M $652M $651M $635M $597M
Dividends and buybacks $3.4B $4.4B $7.9B $3.9B $1.1B $2.8B $652M $651M $635M $597M
Balance sheet
Cash and short-term investments $6.6B $14.4B $8.6B $1.5B $2.5B $2.0B $5.0B $2.4B $1.8B $715M
Total debt $21.4B $34.1B βˆ’$12.6B βˆ’$11.8B $15.6B $10.8B $8.1B $7.9B $7.2B $3.2B
Finance lease liabilities $0.0M $0.0M $0.0M $3.0M $2.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $23.7B $49.9B $126.7B $10.0B $29.0B $14.3B $11.3B $7.5B $20.8B $5.6B
Current liabilities $12.6B $26.1B $73.3B $8.3B $12.2B $4.9B $3.7B $3.1B $5.5B $2.3B
Inventory $7.4B $17.0B $4.1B $4.3B $2.4B $2.1B $2.3B $2.1B $1.1B $1.2B
Property and equipment, net $23.5B $36.2B $9.9B $10.1B $10.0B $5.8B $5.7B $5.9B $3.5B $3.5B
Total assets $79.5B $191.9B $187.9B $69.3B $70.9B $45.7B $41.4B $38.6B $36.6B $21.6B
Total liabilities $52.3B $90.5B $92.0B $27.8B $31.8B $18.7B $14.3B $13.8B $12.8B $7.5B
Shareholders' equity $26.0B $100.3B $94.3B $41.0B $38.5B $26.4B $26.6B $24.3B $23.4B $13.9B
Margins
Gross margin 21.8% 108.8% 91.4% 53.4% 65.4% 36.6% 35.5% 32.8% 33.0% 34.5%
EBITDA margin 16.9% βˆ’4.0% 12.5% 17.4% 12.3% 24.5% 23.6% 10.5% 16.6% 16.9%
Net margin 9.0% 9.9% 17.0% 2.3% βˆ’14.5% 51.5% 45.1% 6.4% 10.5% βˆ’11.4%
FCF margin βˆ’14.0% βˆ’11.3% 15.4% βˆ’4.9% 14.2% 11.9% βˆ’0.6% 8.2% 7.1% 3.3%
Returns
Return on capital β€” βˆ’1.5% 0.5% 0.8% βˆ’1.2% 3.7% 4.3% 0.3% 0.8% 1.1%
Return on capital employed β€” βˆ’1.3% 0.5% 0.6% βˆ’1.0% 4.0% 5.0% 0.3% 1.5% 2.0%
Return on equity 16.6% 1.8% 4.0% 0.7% βˆ’7.4% 19.9% 22.1% 1.7% 3.0% βˆ’4.2%
Return on assets 5.9% 0.9% 2.0% 0.4% βˆ’4.2% 11.1% 13.5% 1.1% 1.9% βˆ’2.7%
Growth
Revenue growth βˆ’1.3% βˆ’75.8% 93.6% βˆ’4.8% βˆ’5.2% βˆ’38.4% 3.6% βˆ’49.2% 1.6% 1.9%
Net income growth βˆ’43.8% βˆ’73.2% 231.8% βˆ’87.1% βˆ’692.6% β€” βˆ’9.3% βˆ’92.8% 66.2% βˆ’210.8%
EPS growth βˆ’42.8% βˆ’79.6% 130.7% βˆ’86.5% βˆ’698.5% β€” βˆ’1.2% βˆ’92.0% 78.7% βˆ’210.7%
FCF growth βˆ’273.2% β€” β€” βˆ’130.5% β€” βˆ’48.5% βˆ’105.0% β€” βˆ’11.6% βˆ’52.7%
Share count change βˆ’9.5% 42.3% 44.9% βˆ’3.3% βˆ’1.5% βˆ’26.0% βˆ’8.2% βˆ’9.9% βˆ’6.8% 0.0%
Financial health
Net debt / EBITDA 1.8x β€” βˆ’7.5x βˆ’3.6x 5.2x 2.9x 1.0x 7.8x 4.8x 2.1x
Debt / equity 0.8x 0.3x βˆ’0.1x βˆ’0.3x 0.4x 0.4x 0.3x 0.3x 0.3x 0.2x
Interest coverage 6.1x β€” 11.9x 0.8x βˆ’0.9x 3.8x 3.9x 0.3x 1.3x 1.6x
Current ratio 1.9x 1.9x 1.7x 1.2x 2.4x 2.9x 3.0x 2.4x 3.8x 2.4x
Quick ratio 1.3x 1.3x 1.7x 0.7x 2.2x 2.5x 2.4x 1.7x 3.6x 1.9x
Capital allocation
Capex / revenue 7.9% 4.7% 5.5% 11.5% 5.9% 6.3% 5.1% 4.6% 4.2% 4.9%
Stock comp / revenue 0.5% 0.2% 0.4% 0.4% 0.5% 0.5% 0.6% 0.9% 0.8% 0.6%
Payouts / FCF β€” β€” 226.9% β€” 38.4% 185.7% β€” 119.9% 132.3% 263.0%
Quality scores
Piotroski F-score β€” 4.0 5.0 5.0 6.0 6.0 6.0 4.0 9.0 6.0
Altman Z'' 3.2 2.4 3.5 1.4 2.3 1.5 1.8 0.7 2.7 βˆ’0.5
Accruals ratio 9.9% 1.4% βˆ’0.5% βˆ’0.7% βˆ’10.1% 7.2% 12.1% βˆ’1.1% βˆ’0.2% βˆ’4.6%

Source: SEC EDGAR XBRL filings (CIK 0001666700). Data updated October 10, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open